Z-LEHD-fmk Options
The key end issue was the protection and tolerability of sifalimumab. Remedy-emergent adverse functions (AEs) and serious AEs (SAEs) as well as their severity, outcome, and any marriage towards the analyze medication have been recorded from the investigator through the research. AEs ended up deemed more likely to be connected with study medication